India proposes wider import gateway network for medicines and medical devices

The Ministry of Health and Family Welfare has proposed expanding India’s authorised import gateways for drugs, medical devices and cosmetics, adding inland clearance locations and Noida International Airport to improve healthcare logistics.

Announced on 3 November, the proposed amendment to Rule 43A of the Drugs Rules, 1945, aims to enable clearance closer to manufacturing facilities, warehouses and distribution centres. The ministry expects shorter inland transport distances, lower logistics costs and fewer delays. The changes remain at the proposal stage.

Which locations are proposed for inclusion?

The proposed additions cover Inland Container Depots (ICDs), a Special Economic Zone (SEZ) and an airport across five states.

Noida International Airport is proposed for drug imports by air. The ministry also identified Dhannad and Tihi ICDs in Indore, Madhya Pradesh, as part of the existing authorised network.

Objections and suggestions may be submitted to the ministry’s Under Secretary for Drugs Regulation or emailed to [email protected].

Why does gateway authorisation matter?

Rule 43A determines the designated entry points through which drugs can legally enter India. Authorisation therefore has a direct bearing on the routes available to importers and the locations through which consignments can be processed.

In a separate communication on port mapping, the Central Drugs Standard Control Organization (CDSCO) explained that notified entry points had been linked to its port offices through the customs electronic gateway, ICEGATE. It asked customs authorities to refer import Bills of Entry to the appropriate CDSCO offices.

The communication also requested that consignments of drugs, medical devices and cosmetics be permitted through notified entry points. This establishes the regulatory context for expanding the network: adding locations must be accompanied by their integration into the clearance process.

How are healthcare imports assessed for clearance?

CDSCO’s published guidance describes a process in which importers file a Bill of Entry with customs through ICEGATE. Relevant consignments are then referred electronically to CDSCO port offices for a No Objection Certificate (NOC).

Port officers examine the submitted documents and determine whether additional checks are necessary. These may include inspection of labelling and markings, drawing samples, or sending samples to a government or approved laboratory for testing.

Depending on the examination, the consignment may be recommended for release. The procedure combines document scrutiny with inspection and testing where required, rather than treating every shipment identically.

The proposed increase in gateway locations would operate within this wider regulatory system. Its logistics objective is to broaden access to clearance facilities while retaining the applicable checks on imported healthcare products.

How does digital customs processing support the network?

India’s customs technology provides a mechanism for coordinating clearance across multiple agencies. According to the National Informatics Centre, ICEGATE connects the Indian Customs Electronic Data Interchange System with traders and regulatory bodies.

The Single Window Interface for Facilitating Trade allows importers and exporters to submit clearance documents at one online point. Where another regulator’s permission is required, the system can obtain it electronically without requiring the trader to approach each agency separately.

The e-Sanchit facility supports electronic submission of supporting documents. These systems provide the digital foundation for processing consignments across a geographically distributed network of authorised gateways, linking customs assessment with the permissions required from sector regulators.